Skip to main content

Contact Lens Wear

0
Pipeline Programs
4
Companies
8
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Bausch Health
Bausch HealthQUEBEC, Quebec, Canada
5 programs
ABT12 Multi-Purpose SolutionN/A1 trial
BL-300-PFM04N/A1 trial
Complete MPSN/A1 trial
Custom Samfilcon B Contact LensesN/A1 trial
Kalifilcon A Daily Disposable Contact LensesN/A1 trial
Active Trials
NCT03897751Completed252Est. Aug 2019
NCT04175340Completed369Est. Feb 2020
NCT02701556Completed396Est. Oct 2015
+2 more trials
Bausch + Lomb
Bausch + LombNJ - Bridgewater
5 programs
Complete MPSN/A
Custom Samfilcon B Contact LensesN/A
ABT12Phase N/A
BL-300-PFM04Phase N/A
Biotrue ONEdayPhase N/A
Alcon
AlconFORT WORTH, TX
2 programs
Biotrue multipurpose solutionN/A1 trial
FID 112903N/A1 trial
Active Trials
NCT01252134Completed22Est. Feb 2011
NCT01132287Completed92Est. Nov 2010
Johnson & Johnson
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
Vistakon Investigational Multi-Purpose Solution IIN/A1 trial
Active Trials
NCT01055457Completed315Est. May 2010

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Bausch HealthBL-300-PFM04
Bausch HealthKalifilcon A Daily Disposable Contact Lenses
Bausch HealthABT12 Multi-Purpose Solution
Bausch HealthCustom Samfilcon B Contact Lenses
Bausch HealthComplete MPS
AlconBiotrue multipurpose solution
AlconFID 112903
Johnson & JohnsonVistakon Investigational Multi-Purpose Solution II

Clinical Trials (8)

Total enrollment: 1,782 patients across 8 trials

NCT04175340Bausch HealthBL-300-PFM04

A Safety and Effectiveness Study of a New Preservative Free Rewetting Drop

Start: Nov 2019Est. completion: Feb 2020369 patients
N/ACompleted
NCT04158466Bausch HealthKalifilcon A Daily Disposable Contact Lenses

A Study to Evaluate the Safety and Efficacy of Kalifilcon A Daily Disposable Contact Lens

Start: May 2019Est. completion: Nov 2019252 patients
N/ACompleted
NCT03897751Bausch HealthABT12 Multi-Purpose Solution

A Safety and Effectiveness Study of BL-ABT12 Multi-Purpose Solution for Use by Participants With Soft Contact Lenses

Start: Mar 2019Est. completion: Aug 2019252 patients
N/ACompleted
NCT03897712Bausch HealthCustom Samfilcon B Contact Lenses

A Study to Evaluate the Safety and Effectiveness of a Silicone Hydrogel Custom Contact Lens When Compared to Alden Optical HP Sphere Lens

Start: Feb 2019Est. completion: Aug 201984 patients
N/ACompleted
NCT02701556Bausch HealthComplete MPS

A Safety and Effectiveness Study of a New Contact Lens Cleaning and Disinfecting Solution

Start: May 2015Est. completion: Oct 2015396 patients
N/ACompleted
NCT01252134AlconBiotrue multipurpose solution

Evaluation of Silicone Hydrogel Lens Wettability With Marketed Lens Care Solutions

Start: Nov 2010Est. completion: Feb 201122 patients
N/ACompleted
NCT01132287AlconFID 112903

An Evaluation of a Marketed Lubricated Eye Drop in Soft Contact Lens Wearers Who Experience Ocular Dryness

Start: Apr 2010Est. completion: Nov 201092 patients
N/ACompleted
NCT01055457Johnson & JohnsonVistakon Investigational Multi-Purpose Solution II

Vistakon Investigational Multi-purpose Contact Lens Care Solution.

Start: Nov 2009Est. completion: May 2010315 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.